Cargando…
2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Breast Cancer
Wendy Hn. Vogel, MSN, FNP, AOCNP(®), of Wellmont Cancer Institute discusses results from a study in hormone receptor–positive metastatic breast cancer (MONALEESA-7), two studies in the metastatic HER2-positive setting (SOPHIA and NALA), as well as a new analysis of the TAILORx trial and a study on t...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520728/ https://www.ncbi.nlm.nih.gov/pubmed/33364068 http://dx.doi.org/10.6004/jadpro.2019.10.6.6 |